{
  "docId": "019de075-881d-736b-8f07-b074ed7dfeb5",
  "docSlug": "6a57ccf571f205aca9c4c1050696b3ed",
  "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Renovaro Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 32,
  "pageCount": 43,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/32",
  "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5",
  "deckJsonHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5.json",
  "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.86,
        "x": 0.07,
        "y": 0.32
      },
      "kind": "list",
      "text": "Caring Cross, a non-profit corporation, has shown that their proprietary CAR-T cells cure HIV in a mouse model; studies in humans have begun\nCAR-T is a promising therapy, but the selection of the cells is difficult, increasing cost ($300,000-$450,000 per person) and side effects\nRenovaro's proprietary “special sauce” technology that could increase uptake of transplanted cells for RENB-HV-01 could also potentially enhance the selection of CAR-T cells\nRenovaro has entered into a profit-sharing sub-license with Caring Cross for a key component of this technology",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "536dcf9c-6c9a-4315-97f9-329bf5d844e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.86,
        "x": 0.07,
        "y": 0.83
      },
      "kind": "paragraph",
      "text": "Renovaro would share in profits if the product is commercialized",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5051a7b7-28a5-4ec6-812e-76c14c8841ef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.86,
        "x": 0.07,
        "y": 0.71
      },
      "kind": "paragraph",
      "text": "If successful, this approach to CAR-T gene therapy could increase the selection of cells, potentially decreasing cost and side effects and expanding the number of people who could be treated",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b82b631-8252-4e01-9613-a77425e86bc0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.09
      },
      "kind": "title",
      "text": "RENB-HV-01: POTENTIAL TO INCREASE SELECTION OF CAR-T CELLS FOR HIV TREATMENT OR CURE",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ec16d96-18cf-4948-81f6-2ffb58f92f36",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 41,
      "from": 20,
      "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}